Novel diphenyl esters of peptidyl α-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin

By Pietrusewicz Ewa   Sieńczyk Marcin   Oleksyszyn Józef  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 6, 2009-12 ,pp. : 1229-1236

Informa Healthcare

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibitors: X-ray Crystallographic Structure of the Adduct of Human Isozyme II with the Perfluorobenzoyl Analogue of Methazolamide. Implications for the Drug Design of Fluorinated Inhibitors

By Abbate Francesco   Casini Angela   Scozzafava Andrea   Supuran Claudiu T.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Iss. 4, 2003-01 ,pp. : 303-308

Informa Healthcare

Access to resources Recommend Favorite

Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies

By He Lufen   Zhou Lu   Wang Taijin   Li Zicheng   Tang Xiangyang  

Molecular Simulation, Vol. 39, Iss. 8, 2013-07 ,pp. : 640-652

Taylor & Francis Ltd

Access to resources Recommend Favorite

The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase

By Lindell S.D.   Ort O.   Lummen P.   Klein R.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 511-514

Elsevier

Access to resources Recommend Favorite

Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence

By Cicero Arrigo FG   Tartagni Elisa   Ertek Sibel  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 863-868

Informa Healthcare

Access to resources Recommend Favorite